Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-015213
Filing Date
2025-05-21
Accepted
2025-05-21 16:47:34
Documents
1
Period of Report
2025-05-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5998
  Complete submission text file 0001127602-25-015213.txt   7381
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Issuer) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 321 HARRISON AVE, 8TH FL BOSTON MA 02118
Business Address
Kasraian Kasra (Reporting) CIK: 0002068538 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41374 | Film No.: 25973709